GEODON
Drug
PFIZER INC.
Total Payments
$1.7M
Transactions
1,664
Doctors
16
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $15,785 | 12 | 1 |
| 2020 | $228,056 | 266 | 2 |
| 2019 | $656,070 | 538 | 11 |
| 2018 | $180,131 | 369 | 3 |
| 2017 | $585,946 | 479 | 4 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.6M | 1,603 | 97.4% |
| Consulting Fee | $27,342 | 17 | 1.6% |
| Travel and Lodging | $11,077 | 32 | 0.7% |
| Food and Beverage | $4,894 | 12 | 0.3% |
Payments by Type
Research
$1.6M
1,603 transactions
General
$43,313
61 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A PHASE 3 MULTICENTER FOURWEEK RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER CURRENT OR MOST RECENT EPISODE MANIC | PFIZER INC. | $1.3M | 0 |
| 26WEEK OPENLABEL EXTENSION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER MOST RECENT EPISODE MANIC | PFIZER INC. | $352,566 | 0 |
Top Doctors Receiving Payments for GEODON
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cincinnati, OH | $1.6M | 1,603 |
| , MD | Psychiatry | Glen Oaks, NY | $9,102 | 4 |
| , M.D | Endocrinology, Diabetes & Metabolism | Setauket, NY | $7,491 | 7 |
| , MD | Pediatrics | Ann Arbor, MI | $7,105 | 7 |
| , M.D | Sleep Medicine | Columbus, OH | $4,746 | 2 |
| , MD MPH | Sleep Medicine | Santee, CA | $1,716 | 4 |
| , MD | Child & Adolescent Psychiatry | Gainesville, FL | $1,670 | 6 |
| , MD | Psychiatry | Orange City, FL | $1,612 | 5 |
| , MD | General Practice | Rochester, NY | $1,524 | 4 |
| , DO | Dermatology | Marion, OH | $1,519 | 2 |
| , M.D | Child & Adolescent Psychiatry | Orlando, FL | $1,161 | 3 |
| , M.D | Child & Adolescent Psychiatry | Cincinnati, OH | $1,153 | 3 |
| , MD | Child & Adolescent Psychiatry | Smyrna, GA | $1,062 | 3 |
| , M.D | Child & Adolescent Psychiatry | Atlanta, GA | $1,062 | 3 |
| , M.D | Family Medicine | Little Rock, AR | $1,054 | 3 |
| , MD | Child & Adolescent Psychiatry | Baltimore, MD | $895.74 | 4 |
| , MD, PA | Child & Adolescent Psychiatry | Coral Gables, FL | $441.76 | 1 |
Ad
Manufacturing Companies
- PFIZER INC. $1.7M
- UPJOHN US 1 LLC $6,676
Product Information
- Type Drug
- Total Payments $1.7M
- Total Doctors 16
- Transactions 1,664
About GEODON
GEODON is a drug associated with $1.7M in payments to 16 healthcare providers, recorded across 1,664 transactions in the CMS Open Payments database. The primary manufacturer is PFIZER INC..
Payment data is available from 2017 to 2021. In 2021, $15,785 was paid across 12 transactions to 1 doctors.
The most common payment nature for GEODON is "Unspecified" ($1.6M, 97.4% of total).
GEODON is associated with 2 research studies, including "A PHASE 3 MULTICENTER FOURWEEK RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED PARALLELGROUP EFFICACY AND SAFETY TRIAL OF FLEXIBLE DOSES OF ORAL ZIPRASIDONE IN CHILDREN AND ADOLESCENTS WITH BIPOLAR I DISORDER CURRENT OR MOST RECENT EPISODE MANIC" ($1.3M).